Advertise your business here! 🚀

Contact us now and get more customers.

Smiling woman thumbs up

Cordenpharma To Expand Greenfield Facility In Switzerland For More Than €500 Million

factory
Mar 05, 2025
Article Source LogoConstruction Review
Construction Review

Pharmaceutical and biotechnology giant, CordenPharma, has unveiled plans to expand its large-scale peptide manufacturing site, Greenfield facility, in Basel, Switzerland. The construction of the new peptide platform will cost CordenPharma more than €500 million.

Location: Basel region in Muttenz, Switzerland

Client: CordenPharma

Project scope: Expansion and capacity addition

Cost: €500 million +

Developer: N/A

Start of construction date: 2025

Completion of construction date: 2027

Facility operational date: 2028

New facility reactor capacity: 5,000 L +

The Greenfield facility expansion project is part of CordenPharma’s massive €1 billion + investment for construction projects across its more than 10 facilities globally. This will take precedence over the course of three years, and will target a bulk of its technology platforms.

The latest €500 million + investment for the Greenfield facility in Switzerland is part of the pharmaceutical company’s goal of expanding their Peptide Platform business by 2028. Sales target stands at more than €1 billion.

The new facility in the Basel region in Muttenz will be located in the European pharma hub, Getec Park. Sitting 8 km outside of Basel, the strategic location for the expansion of CordenPharma’s Greenfield facility was based on several key factors.

These include the already established large-scale chemical manufacturing facilities in the area, and the existing infrastructure implicated in peptide manufacturing. This will include resources like materials, and other technologies and their processes. Also sought by CordenPharma for the expansion of the Greenfield facility in Switzerland is the good and robust transportation network and favorable logistics. This will ensure efficiency in the supply of the company’s pharmaceutical products.

CordenPharma’s Greenfied facility in Switzerland will also feature specs in automation and improved digitalization. Also included the development plans are the manufacturing platforms that will cumulatively have a Solid Phase Peptide Synthesis (SPPS) reactor capacity of more than 5,000 liters.

The construction project will also create about 300 jobs, alongside stimulating growth to the region’s economy, and Getec Park’s innovation.

Another factor that cannot be understated in the more than €500 million investment to expand CordenPharma’s Greenfield facility is the essence of the “pharma hub”. This is a pool steaming with talent in the pharmaceutical and biotechnology sectors in the whole of Europe.

Not to be left out is, of course the talk of town, “sustainabilty”. There is a surrounding industrial park in the facility’s vicinity in the Getec Park pharma hub and this will be paramount in multiple ways. Closed loop energy cycles – with the same call for the industrial materials, and game-changing waste-to-value streams are some of the faces representing the doors to net-zero in CordenPharma’s Greenfield facility expansion project.

The Switzerland-based pharmaceutical company is also co-currently expanding its Boulder facility in the United States at Colorado. Boulder (formerly Pfizer/Hospira) is expected to have doubled its SPPS reactor capacity at more than 42,000 liters by project completion date in 2028.

Also read: Turner Tops Out Massachusetts General Hospital, Building Healthcare for a Changing Climate

Also read: Östra Hospital expansion: Skanska to expand Eastern Hospital in Sweden for SEK 500 million

Share Your Insights!

Publish your articles, reach a global audience, and make an impact.

0
Recent Comments

Factory Related News You might want to check out

View by
Stellantis Ceo Targets Us Turnaround As Carmaker Faces $1.7 Billion Hit From Tariffs This Year
Stellantis Ceo Targets Us Turnaround As Carmaker Faces $1.7 Billion Hit From Tariffs This Year
Plant
30 July 2025
factory
Amazon Breaks Ground On Massive 930,000 Square Foot Facility In Port Of Little Rock, Arkansas
Amazon Breaks Ground On Massive 930,000 Square Foot Facility In Port Of Little Rock, Arkansas
Construction Review
30 July 2025
factory
Stellantis Faces $1.7 Billion Hit From U.S. Tariffs This Year
Stellantis Faces $1.7 Billion Hit From U.S. Tariffs This Year
Manufacturing Net
29 July 2025
factory
Japan'S $550B Deal Could Fund Taiwanese Chip Plants In Usa
Japan'S $550B Deal Could Fund Taiwanese Chip Plants In Usa
Asia Manufacturing Review
29 July 2025
factory
370-Million Mile Hail Mary Saves Camera Aboard Nasa’S Jupiter Orbiter
370-Million Mile Hail Mary Saves Camera Aboard Nasa’S Jupiter Orbiter
Manufacturing Net
24 July 2025
factory
Clorox Comes Clean About $380 Million Ransomware Nightmare
Clorox Comes Clean About $380 Million Ransomware Nightmare
Manufacturing Net
23 July 2025
factory
Kazakhstan Launches $26.7 Billion Push To Boost Industrial Growth
Kazakhstan Launches $26.7 Billion Push To Boost Industrial Growth
Asia Manufacturing Review
23 July 2025
factory
Taiwan Rolls Out Ai Strategy To Drive $510 Billion Economy
Taiwan Rolls Out Ai Strategy To Drive $510 Billion Economy
Asia Manufacturing Review
23 July 2025
factory
Hewlett Packard Owed Nearly $1 Billion From Late Tech Tycoon'S Estate, Court Says
Hewlett Packard Owed Nearly $1 Billion From Late Tech Tycoon'S Estate, Court Says
Manufacturing Net
22 July 2025
factory
Stellantis Warns Of $2.7 Billion Loss
Stellantis Warns Of $2.7 Billion Loss
Manufacturing Net
21 July 2025
factory
Siemens Among Companies Pledging To Invest $700 Billion In Germany Over Next 3 Years
Siemens Among Companies Pledging To Invest $700 Billion In Germany Over Next 3 Years
Manufacturing Net
21 July 2025
factory
Nigeria Clinches $20B China Deal For Manufacturing And Energy
Nigeria Clinches $20B China Deal For Manufacturing And Energy
Asia Manufacturing Review
21 July 2025
factory